PERSPECTA

News from every angle

← Back to headlines

GLP-1 Drugs Like Mounjaro and Ozempic Show Benefits for Diabetes and Weight Loss

New research indicates that the reduction in obesity-related disease risk is directly tied to the amount of weight lost using GLP-1 drugs, such as Ozempic. Additionally, Lilly's Mounjaro has been found to outperform other GLP-1s for some type 2 diabetes patients.

29 May, 11:03 — 29 May, 11:03
PostShare

Sources

Showing 1 of 2 sources
YahooMostly Factual72d ago

Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients

Read full article →

Coverage Timeline

First report: index-hr · 28 May, 19:58Full coverage: 2 · 15hWindow: 15h
Left-leaningCenterRight-leaning
index-hr28 May, 19:58First to report

Istraživanje: Lijekovi poput Ozempica smanjuju rizik od bolesti

15h later
Yahoo29 May, 11:03Latest update

Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients

Related Stories

Popular Breakfast Product May Reduce 'Bad' Cholesterol and Heart Disease Risk

45m ago

Lagos Law Student Dies After Allegedly Jumping From Building

55m ago

German Pediatricians Warn of Impending Crisis in Nursing Care

1h ago

Microplastics' Health Impact: Scientists Find Them Throughout Human Body

1h ago